Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres.
暂无分享,去创建一个
G Chaine | A Erginay | A Chabouis | P Massin | G Reach | E Vicaut | A. Erginay | A. Chabouis | T. Méas | P. Guillausseau | M. Laloi-Michelin | G Slama | M Berdugo | T Meas | M Laloi-Michelin | V Jouis | P-J Guillausseau | J M'bemba | R Cohen | M Marre | P Chanson | J. M'bemba | M. Berdugo | Michel Marre | P. Massin | Eric Vicaut | Philippe Chanson | G. Slama | Gérard Reach | V. Jouis | Gilles Chaine | Régis Cohen
[1] J. Sahel,et al. [Detection, monitoring and treatment of diabetic retinopathy. Recommendations of ALFEDIAM. Committee of above-mentioned experts and validated by the board of directors and scientific board of ALFEDIAM]. , 1996, Diabetes & metabolism.
[2] A. Erginay,et al. OPHDIAT: a telemedical network screening system for diabetic retinopathy in the Ile-de-France. , 2008, Diabetes & metabolism.
[3] Présentation par Bernard Charbonnel. Les recommandations de l’ANAES sur le suivi du patient diabétique de type 2 à l’exclusion du suivi des complications , 1999 .
[4] D. DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.
[5] A Erginay,et al. OPHDIAT: quality-assurance programme plan and performance of the network. , 2008, Diabetes & metabolism.
[6] F. Jónasson,et al. Active prevention in diabetic eye disease. A 4-year follow-up. , 2009, Acta ophthalmologica Scandinavica.
[7] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[8] J. Sahel,et al. [Recommendations of the ALFEDIAM (French Association for the Study of Diabetes and Metabolic Diseases) for the screening and surveillance of diabetic retinopathy]. , 1997, Journal francais d'ophtalmologie.
[9] E. Agardh,et al. The Five‐year Incidence of Blindness after Introducing a Screening Programme for Early Detection of Treatable Diabetic Retinopathy , 1993, Diabetic medicine : a journal of the British Diabetic Association.
[10] Stephen J. Aldington,et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. , 1997, Ophthalmology.
[11] R. Bourrel,et al. Les modalités de suivi des diabétiques non insulino traités en France métropolitaine durant l'année 1998 , 2008 .
[12] P. Scanlon,et al. Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy , 2003, The British journal of ophthalmology.
[13] Cécile Delcourt,et al. Visual impairment in Type 2 diabetic patients , 1995 .
[14] D L DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.
[15] J. Fleiss. Statistical methods for rates and proportions , 1974 .
[16] H. Ahmadieh,et al. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research Group. , 1988, Ophthalmology.